Plasma irisin and its associations with oxidative stress in athletes suffering from overtraining syndrome

Physiol Int. 2020 Dec 31;107(4):513-526. doi: 10.1556/2060.2020.00037.

Abstract

Irisin is a novel exercise-induced myokine that may be involved in regulating energy metabolism. We determined whether overtraining syndrome (OTS) and its biochemical markers are associated with plasma irisin levels in athletes. Seven severely overtrained athletes (OA) and 10 healthy control athletes (CA) were recruited and examined at the time of diagnosis (baseline) and after 6- and 12-months follow-up. Training volume and intensity were initially restricted but progressively increased in OA as OTS symptoms alleviated; CA continued their normal training routine. A maximal cycle ergometer test was performed with irisin analyzed before and after the test. Before the exercise test, irisin levels tended to be lower in OA than in CA at baseline (154.5 ± 28.5 vs. 171.7 ± 58.7 ng/mL). In both groups, at rest irisin levels changed only marginally during follow-up and were not affected by maximal exercise, nor were they associated with physical performance or body fat percentage. Irisin concentration at rest correlated positively with an oxidative stress marker, malondialdehyde (MDA) and negatively with an antioxidant protection marker, oxygen radical absorbance capacity (ORAC) in response to the exercise test in OA at baseline. Our findings help to clarify the possible contribution of irisin and its association with oxidative stress in the pathophysiology of OTS.

Keywords: exercise; myokine; overtraining; recovery.

MeSH terms

  • Athletes*
  • Biomarkers / blood
  • Case-Control Studies
  • Cumulative Trauma Disorders / blood*
  • Cumulative Trauma Disorders / diagnosis
  • Cumulative Trauma Disorders / etiology
  • Cumulative Trauma Disorders / physiopathology
  • Cytokines / blood
  • Fibronectins / blood*
  • Humans
  • Inflammation Mediators / blood
  • Malondialdehyde / blood
  • Oxidative Stress*
  • Oxygen Radical Absorbance Capacity
  • Physical Conditioning, Human / adverse effects*
  • Syndrome
  • Time Factors

Substances

  • Biomarkers
  • Cytokines
  • FNDC5 protein, human
  • Fibronectins
  • Inflammation Mediators
  • Malondialdehyde